This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Erythema multiforme

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Erythema multiforme is an acute, self limiting and at times recurring skin condition thought to occur due to a hypersensitivity reaction against certain infections and medications (1).

Erythema multiforme is a term describing target lesions - circular lesions often with central blister with a symmetrical peripheral distribution, usually on limbs.

There are often mouth, genital and eye ulcers and fever - Stevens-Johnson syndrome.

Previously the disease was thought to represent part of a clinical spectrum of disease which in ascending order of severity includes, erythema minor, erythema major (often known as Stevens-Johnson syndrome [SJS]), and toxic epidermal necrolysis (TEN) (1).

With its minimal mucous membrane association and <10% epidermal detachment, erythema multiforme is now considered to be a distinct condition from SJS and TEN (1).

Frequently seen in adults between the ages of 20-40 years (1).

Click here for an example image of erythema multiforme

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.